Overview

Efficacy of Ivermectin in COVID-19

Status:
Recruiting

Trial end date:
2020-07-01

Target enrollment:

Participant gender:

Summary

It is a randomized controlled trial to assess the efficacy of Ivermectin in COVID-19. Patient recruited will be assigned to two groups one group will be given ivermectin with standard chloroquine regimen and the other group will be receiving chloroquine only. Out come will be recorded by documenting PCR reports at 48, 96 and 144 hours.

Phase:

N/A

Details

Lead Sponsor:

Combined Military Hospital, Pakistan

Treatments:

Ivermectin